Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
P 2 (1)

Trial Status

Recruiting2
Not Yet Recruiting1
Active Not Recruiting1

Clinical Trials (4)

Showing 4 of 4 trials
NCT03516942Active Not RecruitingPrimary

Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment

NCT07405476Phase 2Recruiting

Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

NCT06746012Not ApplicableRecruitingPrimary

Designing a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers

NCT07143487Not ApplicableNot Yet Recruiting

Family Communications After Genetic Testing

Showing all 4 trials

Research Network

Activity Timeline